Fitness Trends Monobody Based Therapeutic Drugs Market | Page 2
Research in the field of Monobody
Researchers at the University of Illinois, Chicago identified a monobody, NS1, which can block
oncogene activity. 30% of all cancers are due to RAS mutation. RAS mutation is also found in
90% of pancreatic cancers and frequently occurs in colon cancer, lung cancer and melanoma.
The NS1 monobody bind to RAS protein molecule and inhibits its oncogenic activity.
Monobody – a better alternative
Antibodies are successful tools used in diagnostics, purification, and therapeutics. Antibodies
have their limitations also like high product cost and low stability. Alternative tools based on
nucleic acid (aptamers), polypeptides (engineered binding proteins) and inorganic matrices have
received attention recently. With increasing research activities for drug development in cancer,
more information would be gathered with respect to monobodies too. Because of high
specificity and affinity monobodies have potential and can be used in organ transplant in near
future and can affect the antibodies market. Successful outcomes will boost investors to develop
this technology and address the unmet need of cancer patients undergoing antibody therapy.
Use of monobodies as therapeutic drug improves patient situation and hence companies are
striving to develop monobodies to be used as therapeutic drugs in the treatment of cancer.
Report includes chapters which deeply display the following deliverable about industry :
• Monobody Based Therapeutic Drugs Market Research Objective and Assumption
• Monobody Based Therapeutic Drugs Market Purview - Report Description, Executive Summary,
and Coherent Opportunity Map (COM)
• Monobody Based Therapeutic Drugs Market Dynamics, Regulations, and Trends Analysis -
Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Monobody Based Therapeutic Drugs Market, By Regions
• Monobody Based Therapeutic Drugs Market Competition by Manufacturers including
Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and
Product Type.
• Monobody Based Therapeutic Drugs Market Manufacturers Profiles/Analysis including Company
Basic Information, Manufacturing Base and Its Competitors.
• Monobody Based Therapeutic Drugs Market Manufacturing Cost Analysis including Key Raw
Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.